PharmaSignal.si
Four things to build on drug signals found early, in six parts.
Drug safety is a search for signals.
After a medicine is approved, rare side effects surface in reports, records and research papers. Spotting the signal early, among millions of reports, protects patients. For a startup, the industry’s own term, with SI after the dot.
Reports read the day they arrive.
A drug company has every adverse-event report read and grouped the day it comes in.
Patterns across all medicines.
An agency watches reports for every drug at once, and sees links no single company could.
Every paper, checked.
A service reads each new paper for mentions of a client’s medicines and their side effects.
Signals in the market too.
A firm tracks prescriptions after a launch and tells the company how the medicine is really being used.
This name is waiting for its builder.
Everyone above is made up. The name is real, and it is for sale.
Those are only the uses we can picture. Someone who is a real innovator, a creative destroyer in Joseph Schumpeter’s sense, will see in this name something nobody has imagined yet, and build that instead.
It is priced on enquiry, with a reply inside one business day. Payment goes through independent escrow, and the name is pushed to your registrar, usually within 24 hours.
The end.
